ESLA (ESTRELLA IMMUNOPHARMA INC) — 2 tracked funds

Cross-fund · 2 holders

ESLA

ESTRELLA IMMUNOPHARMA INC

CUSIP 297584104

Tracked holders

$742,357

Aggregate value

488,655

Active funds

Funds holding ESLA

Fund	Strategy	Period	Value	% of book	Δ shares	Status
Vanguard	Institutional	Q4 2025	$700,074	—	+29,054	+6.9%
BlackRock	Institutional	Q1 2026	$42,283	—	+13,420	+50.7%
Citadel	Multi-Strategy	Q1 2026	—	—	−64,394	EXITED

Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.